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ARTICLE
Hook3 is a scaffold for the opposite-polarity
microtubule-based motors cytoplasmic dynein-1
and KIF1C
Agnieszka A. Kendrick1, Andrea M. Dickey1*, William B. Redwine1,2*, Phuoc Tien Tran1, Laura Pontano Vaites2, Monika Dzieciatkowska3,
J. Wade Harper2, and Samara L. Reck-Peterson1,4,5
The unidirectional and opposite-polarity microtubule-basedmotors, dynein and kinesin, drive long-distance intracellular cargo
transport. Cellular observations suggest that opposite-polarity motors may be coupled. We recently identified an interaction
between the cytoplasmic dynein-1 activating adaptor Hook3 and the kinesin-3 KIF1C. Here, using in vitro reconstitutions with
purified components, we show that KIF1C and dynein/dynactin can exist in a complex scaffolded by Hook3. Full-length Hook3
binds to and activates dynein/dynactin motility. Hook3 also binds to a short region in the “tail” of KIF1C, but unlike dynein/
dynactin, this interaction does not activate KIF1C. Hook3 scaffolding allows dynein to transport KIF1C toward the microtubule
minus end, and KIF1C to transport dynein toward the microtubule plus end. In cells, KIF1C can recruit Hook3 to the cell
periphery, although the cellular role of the complex containing both motors remains unknown. We propose that Hook3’s ability
to scaffold dynein/dynactin and KIF1C may regulate bidirectional motility, promote motor recycling, or sequester the pool of
available dynein/dynactin activating adaptors.
Introduction
In many eukaryotic organisms, microtubules and the motors
that move on them (kinesins and dynein) power the long-
distance transport of intracellular cargos. Microtubules are
polar structures with their “minus ends” typically located
near microtubule organizing centers. Cytoplasmic dynein-1
(“dynein” here) moves cargos toward the microtubule
minus end, while kinesins that transport cargos over long
distances, such as those in the kinesin-1, -2, and -3 families,
move cargos toward the microtubule plus end (Vale, 2003).
The cargos of these motors include organelles, other
membrane-bound compartments, and large RNA and protein
complexes (Hirokawa and Noda, 2008; Reck-Peterson et al.,
2018).
In many cases, these cargos can be observed rapidly
switching directions. For example, in filamentous fungi, endo-
somes move bidirectionally along microtubules (Wedlich-
So¨ldner et al., 2002; Abenza et al., 2009; Egan et al., 2012)
and also drive the bidirectional motility of hitchhiking cargos
such as peroxisomes, lipid droplets, endoplasmic reticulum,
and ribonucleoprotein complexes (Baumann et al., 2012;
Guimaraes et al., 2015; Salogiannis et al., 2016). In human cells,
examples of cargos that move bidirectionally on microtubules
include lysosomes (Hendricks et al., 2010), secretory vesicles
(Barkus et al., 2008; Schlager et al., 2010), autophagosomes
(Maday et al., 2012), and protein aggregates (Kamal et al., 2000;
Encalada et al., 2011). Purified cargos, such as pigment granules
(Rogers et al., 1997) and neuronal transport vesicles (Hendricks
et al., 2010), exhibit bidirectional motility along microtubules
in vitro. Together, these data suggest that opposite-polarity
motors are present on the same cargos in many organisms
and for many cargo types. There is also evidence that kinesin
localizes dynein to microtubule plus ends (Brendza et al., 2002;
Zhang et al., 2003; Carvalho et al., 2004; Twelvetrees et al.,
2016), suggesting that these motors could be directly coupled.
Given these data, a central question is to determine how
opposite-polarity motors are scaffolded.
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We and others have taken a “bottom-up” approach to study
teams of motors by designing artificial scaffolds bearing
opposite-polarity motors. For example, dynein and kinesin
motors can be scaffolded by DNA origami (Derr et al., 2012) or
short DNA oligomers (Belyy et al., 2016). Such approaches allow
the basic biophysical properties of motor teams to be dissected.
However, studies using physiological motor pairs and scaffolds
are lacking, primarily because these scaffolds have not been
identified or well characterized. One exception is our recent
reconstitution of dynein transport to microtubule plus ends by a
kinesin (Roberts et al., 2014), a process that occurs in vivo in
yeast cells (Moore et al., 2009). In this system, cytoplasmic
dynein-1 and the kinesin Kip2 required two additional proteins
for scaffolding, and both motors were regulated so that Kip2-
driven plus end–directed motility prevails (Roberts et al., 2014;
DeSantis et al., 2017).
How are opposite-polarity motors scaffolded in mammalian
cells? A group of proteins called “dynein activating adaptors” are
emerging as candidate scaffolds (Reck-Peterson et al., 2018;
Olenick and Holzbaur, 2019). Processive dynein motility re-
quires an activating adaptor as well as the dynactin complex
(McKenney et al., 2014; Schlager et al., 2014). Examples of ac-
tivating adaptors include the Hook (Hook1, Hook2, and Hook3),
BicD (BicD1, BicD2, BicDL1, and BicDL2), and ninein (Nin and
Ninl) families of proteins (McKenney et al., 2014; Schlager et al.,
2014; Redwine et al., 2017; Reck-Peterson et al., 2018; Olenick
and Holzbaur, 2019). One piece of evidence supporting the role
of activating adaptors as scaffolds is our recent identification of
an interaction between Hook3 and the kinesin KIF1C using a
proteomics approach (Redwine et al., 2017). KIF1C is a plus
end–directed member of the kinesin-3 family (Dorner et al.,
1998; Rogers et al., 2001), which has been implicated in the
plus end–directed transport of secretory vesicles that move bi-
directionally inmultiple cell types (Schlager et al., 2010; Theisen
et al., 2012). The dynein-activating adaptors BicD2 and BicDL1
may also interact with kinesin motors (Schlager et al., 2010;
Splinter et al., 2010; Novarino et al., 2014). However, it is not
known whether the interactions between dynein-activating
adaptors and kinesins are direct, if dynein and kinesin binding
is achieved simultaneously, or if the dynein activating adaptors
can support motility in both directions.
Here we use Hook3 as a model system to determine if a
physiological scaffold can link the opposite-polarity motors
dynein and KIF1C to allow for motility in both the plus end and
minus end directions. To do so, we perform complex in vitro
reconstitutions with purified human dynein (1.4 MD and 12
subunits), dynactin (1.1 MD and 23 subunits), full-length Hook3
(166 kD as a dimer; see below), full-length KIF1C (246 kD as a
dimer; see below), and microtubules. We identify the binding
site for Hook3 on KIF1C and show that while Hook3 activates
motility when added to dynein/dynactin, it does not activate
motility when added to KIF1C. We also show that Hook3 scaf-
folds dynein/dynactin and KIF1C, resulting in motility toward
either the microtubule plus or minus end without directional
switching. In cells, we show that KIF1C recruits Hook3 to the cell
periphery and that this requires the Hook3-binding site we
identified. Together, this represents the first example of a fully
reconstituted physiological scaffold with opposite-polarity mo-
tors and identifies an excellent model system to continue to
understand the complicated process of bidirectional motility
seen in cells.
Results
Endogenous KIF1C and Hook3 interact specifically
We identified the Hook3–KIF1C interaction using a proximity-
dependent biotinylation technique that relies on a promiscuous
biotin ligase (BioID) with BioID-tagged Hook3 (Roux et al., 2012;
Redwine et al., 2017). KIF1C is a kinesin-3 family member that is
closely related to KIF1A and KIF1B (Dorner et al., 1998). It con-
tains an amino-terminal motor domain and carboxy-terminal
“tail” domain with several regions of predicted coiled-coil, a
forkhead-associated domain, and a proline-rich region (Miki
et al., 2005; Fig. 1 A). KIF1C interacts with the carboxy termi-
nus of Hook3 (Redwine et al., 2017), while dynein and dynactin
interact with Hook3’s amino terminus (McKenney et al., 2014;
Fig. 1 A).
Here, we began by performing a BioID experiment with
BioID-tagged KIF1C to identify the protein interactome of KIF1C.
To perform this experiment with near-endogenous expression
levels of KIF1C (to avoid artifacts of protein overexpression), we
generated KIF1C knockout 293T human cell lines using CRISPR/
Cas9-based gene editing. Cotransfection of 293T cells with Cas9
and guides specific for exon 3 of the KIF1C genomic sequence or
empty vector, followed by clonal selection, yielded two clones
with full depletion of KIF1C and a control cell line (Fig. 1 B). We
then infected one of these cell lines (KIF1CKO, clone #1) and the
control cell line with retroviral KIF1C-BioID-3xFLAG or BioID-
3xFLAG plasmids driven by the murine stem cell virus (MSCV)
promoter to generate stable cells expressing exogenous KIF1C-
BioID or BioID alone (Behrends et al., 2010). The KIF1C protein
expression levels in these cells were similar to endogenous
KIF1C expression levels in 293T cells (Fig. 1 C). To perform BioID
experiments, we lysed cells after growth in biotin-containing
medium and isolated biotinylated proteins using streptavidin
beads. Biotinylated proteins were identified by mass spectrom-
etry (MS), and significant “hits” were determined using a label-
free proteomics approach by comparison to a BioID-alone
control (Zhang et al., 2010; Redwine et al., 2017). Proteins not
present in the BioID control or with an enrichment ratio greater
than threefold and a P value >0.05 relative to the control were
considered significant hits. One of the top hits from this ex-
periment was Hook3 (Fig. 1 D and Table S1). We did not detect
other dynein-activating adaptors, except for Hook1, which was
a significant hit, but had a relatively low peptide count.
To further characterize the interaction between KIF1C and
Hook3, we immunoprecipitated endogenous KIF1C and Hook3
from 293T cells. Immunoblots with antibodies against Hook3 and
KIF1C demonstrated that these proteins coprecipitate (Fig. 1 E).
Because there are three different HOOK homologues in the hu-
man genome (HOOK1, HOOK2, and HOOK3) and because we de-
tected both Hook3 and Hook1 in our KIF1C BioID data, we next
used immunoprecipitation experiments to confirm these inter-
actions and to determine if KIF1C interacted with the third Hook
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homologue, Hook2. We expressed each Hook homologue with an
amino-terminal HaloTag and a carboxy-terminal 3xFLAG tag in
293T cells. Immunoprecipitation of each tagged Hook protein,
followed by immunoblots for endogenous KIF1C, revealed that
endogenous KIF1C coprecipitates with Hook3, but not Hook1 or
Hook2 (Fig. 1 F). The presence of Hook1 in our KIF1C BioID da-
taset was likely due to heterodimerization of Hook1 with Hook3,
rather than Hook1 interacting with KIF1C, as in our previous
BioID experiments with Hook1 and Hook3, we detected Hook1 in
Hook3 datasets and vice versa (Redwine et al., 2017). This is also
consistent with a previous study that suggested possible heter-
odimerization between Hook family members (Xu et al., 2008).
We next asked if Hook3 specifically interacts with KIF1C. The
two most closely related kinesin-3 family members to KIF1C are
KIF1A and KIF1B (Dorner et al., 1998). In addition, the kinesin-1s,
KIF5A, KIF5B, and KIF5C, are well-characterized cargo-
transporting plus end–directed motors. We expressed each of
these kinesins with a carboxy-terminal BioID-3xFLAG tag in
293T cells. Immunoprecipitation of each tagged kinesin,
followed by immunoblots for endogenous Hook3, revealed that
endogenous Hook3 coprecipitates with KIF1C, but not KIF1A,
KIF1B, KIF5A, KIF5B, or KIF5C (Fig. 1 G). We conclude that
endogenous Hook3 and KIF1C interact in a specific manner.
KIF1C is a processive plus end–directed motor, whose motility
is not activated by Hook3
To further explore the interaction between KIF1C and Hook3, we
purified full-length KIF1C tagged with SNAP and 3xFLAG tags at
its carboxy terminus, and full-length Hook3 tagged with a Hal-
oTag at its amino terminus and a 3xFLAG tag at its carboxy
terminus from 293T cells. Each proteinmigrated as a single band
when analyzed by SDS-PAGE (Fig. S1 A). Using total internal
reflection fluorescence (TIRF) microscopy with tetrame-
thylrhodamine (TMR)-labeled KIF1C-SNAP-3xFLAG and Alexa
Fluor 405–labeled microtubules, we visualized the motile
properties of KIF1C on microtubules. Single full-length KIF1C
molecules moved processively toward the microtubule plus end
(Fig. 2 A; Fig. S1, B–D; and Video 1) with an average velocity of
Figure 1. Endogenous Hook3 and KIF1C interact
specifically. (A) Domain organization of KIF1C and
Hook3. KIF1C contains an amino-terminal kinesin motor
domain and regions of predicted coiled coil (CC), a
forkhead-associated domain (FHA), and a proline-rich
(P-rich) region in its carboxy-terminal tail. Hook3 is
largely made up of regions of predicted CC and contains
dynein/dynactin and KIF1C-binding regions (McKenney
et al., 2014; Redwine et al., 2017). The Hook domain,
which is also involved in dynein binding (Schroeder and
Vale, 2016), is indicated. (B) 293T cells were transfected
with control CRISPR/Cas9 (CTRL) or with CRISPR/Cas9-
gRNA specific for KIF1C. KIF1C knockout (KIF1CKO) was
confirmed in two different clones by immunoblotting
with an anti-KIF1C antibody. Clone #1 was selected for
further assays. β-Actin provided a loading control.
(C) KIF1CKO cells were infected with viral particles en-
coding MSCV-driven KIF1C-BioID-3xFLAG plasmid to
obtain near-endogenous KIF1C-BioID protein expression
levels. Immunoblots were performed using the indicated
antibodies. β-Actin provided a loading control. (D) A
volcano plot showing enrichment versus significance of
proteins identified in KIF1C-BioID experiments relative
to control (BioID alone) experiments. Proteins not pre-
sent in the BioID control or with an enrichment ratio
greater than threefold and a P value >0.05 relative to
the control (dashed red lines) were considered signifi-
cant hits. KIF1C, Hook3, and Tc-Tex-1 (DYNLT1, a dynein
light chain) are marked in red. (E) Immunoprecipitation
(IP) of endogenous Hook3 and KIF1C with the indicated
antibodies from 293T cells. Immunoblots were per-
formed with anti-Hook3 or KIF1C antibodies. (F) Human
Hook1, Hook2, and Hook3 tagged with the HaloTag on
their amino termini and 3xFLAG on their carboxy termini
were transiently transfected into 293T cells and im-
munoprecipitated with FLAG affinity resin (FLAG-IP).
Immunoblots were performed with anti-KIF1C and anti-
FLAG antibodies. 3xFLAG-sfGFP provided a control.
Protein molecular weight markers are shown in kilo-
daltons on the anti-FLAG immunoblot. (G)Human KIF1A,
KIF1B, KIF1C, KIF5A, KIF5B, and KIF5C were each tagged with BioID-3xFLAG on their carboxy termini and stably expressed in 293T cells. Tagged proteins were
immunoprecipitated with FLAG affinity resin (FLAG-IP), and immunoblots were performed with anti-Hook3 and anti-FLAG antibodies. BioID-3xFLAG provided a
control. Protein molecular weight markers are shown in kilodaltons on the anti-FLAG immunoblot.
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0.734 ± 0.223 µm/s (Fig. 2 B) and run length of 21.11 µm (Fig. 2
C). We next monitored the interaction of full-length KIF1C-TMR
with full-length Hook3 (Fig. S1 A) labeled with Alexa Fluor 488
via its amino-terminal HaloTag using near-simultaneous two-
color TIRF microscopy. Hook3 alone did not interact with mi-
crotubules (Fig. 2 D, left panel). In contrast, in the presence of
KIF1C, Hook3moved robustly toward microtubule plus ends and
colocalized with KIF1C (Fig. 2 D, right panels; and Video 2). The
presence of Hook3 did not alter KIF1C’s dimerization state as
indicated by photo-bleaching analysis (Fig. S1, C and E). KIF1C’s
velocity, landing rates, and pausing frequency were unchanged
in the presence of Hook3, while a slight reduction in run length
was observed (Fig. 2, E and F; and Fig. S1, C–G). In addition, the
number of processive, diffusive, or static events for KIF1C was
not significantly different in the presence or absence of Hook3
(Fig. S1 H). These data define the single-molecule motile
Figure 2. KIF1C is a highly processive kinesin-3 motor whose motility is not activated by Hook3. (A) Representative kymograph from single-molecule
motility assays with full-length KIF1C tagged with SNAP and 3xFLAG and labeled with TMR via the SNAP tag. Microtubule polarity is marked with minus (–) and
plus (+). (B) A histogram of the velocity of single-KIF1C-TMR molecules fit to a Gaussian (black line, 0.734 ± 0.223 µm/s, mean ± SD, r2 = 0.965). Data from
three independent experiments are shown (n = 433). (C) Run length analysis of KIF1C-TMR. The 1-cumulative frequency distribution was fit to a one-phase
exponential decay (black line). The representative mean decay constant is 21.11 µm (r2 = 0.920, n = 158). (D) Representative kymographs from single-molecule
motility assays with full-length Hook3 tagged at the amino terminus with an Alexa Fluor 488–labeled HaloTag and carboxy terminus with 3xFLAG (Hook3-488;
left panel). KIF1C-TMR in the presence of Hook3-488 (right panels). Colocalized runs can be seen in the merge in white. Microtubule polarity is marked with
minus (–) and plus (+). (E) Velocity (mean ± SD) of KIF1C-TMR–only runs compared with KIF1C-TMR runs in the presence of Hook3-488 (n = 433 for KIF1C only;
n = 716 for KIF1C with Hook3). (F) Run length analysis from KIF1C-TMR–only runs compared with KIF1C-TMR runs in the presence of Hook3-488. The
1-cumulative frequency distribution was fit to a one-phase exponential decay (KIF1C, magenta dotted line; KIF1C with Hook3, black dotted line). The rep-
resentative mean decay constant for KIF1C is 18.89 µm (r2 = 0.932, n = 385) and for KIF1C with Hook3 is 13.77 µm (r2 = 0.901, n = 418). Data were resampled
with bootstrapping analysis, and statistical significance was calculated using an unpaired t test with Welch’s correction; P = 0.0485. Representative data from
three independent experiments are shown.
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properties of KIF1C and show that Hook3 comigrates with
processive KIF1C molecules and only minimally affects KIF1C’s
motile properties.
14 amino acids in the tail of KIF1C are required for
Hook3 binding
We next sought to identify the regions in both KIF1C and Hook3
responsible for their interaction. We began with KIF1C, gener-
ating a series of carboxy-terminal KIF1C truncation constructs,
all of which contained a carboxy-terminal 3xFLAG tag (Fig. 3 A).
We made constructs lacking the carboxy terminus including the
proline-rich region (KIF1C1-820) and lacking the fourth coiled-
coil and the proline-rich region (KIF1C1-785), and a deletion
mutant that removed a short stretch of charged residues as well
as two tryptophans (KIF1CΔ794-807-3xFLAG; Fig. 3 A). We hy-
pothesized that the amino acid content in this region might form
a protein–protein interaction interface in the KIF1C tail sequence
that is otherwise predicted to be mainly unstructured or coiled-
coil. Overexpression of these constructs in 293T cells followed
by FLAG immunoprecipitations revealed that Hook3 binding to
KIF1C is lost when the 14 aa (794–807) between coiled-coils 3 and
4 are deleted (Fig. 3 B). To confirm the requirement of this
Figure 3. 14 amino acids in the tail of KIF1C mediate its interaction with Hook3. (A) Schematic of constructs used to map the region of KIF1C that is
responsible for binding to Hook3. (B) KIF1C-SNAP-3xFLAG constructs were transiently expressed in 293T cells and immunoprecipitated with FLAG affinity resin
(FLAG-IP). Immunoblots were performed with anti-Hook3 and anti-FLAG antibodies. 3xFLAG-sfGFP provided a control. Protein molecular weight markers are
shown in kilodaltons on the anti-FLAG immunoblot. (C) Representative kymographs from single-molecule motility assays with purified KIF1CΔ794-807-TMR in
the presence of Hook3-488. Microtubule polarity is marked with minus (–) and plus (+). (D) Schematic of constructs used to map the region of Hook3 that is
responsible for binding to KIF1C. Hook3NT (aa 1–552), Hook3CT (aa 553–718), Hook3Hook2 (a Hook3 [aa 1–552] and Hook2 [aa 548–719] chimera). (E) HaloTag-
Hook3-3xFLAG constructs were transiently expressed in 293T cells and immunoprecipitated with FLAG affinity resin (FLAG-IP). Immunoblots were performed
with anti-KIF1C and anti-FLAG antibodies. 3xFLAG-sfGFP provided a control. Protein molecular weight markers are shown in kilodaltons on the anti-FLAG
immunoblot. (F) Representative kymographs from single-molecule motility assays of KIF1C-TMR in the presence of Hook3Hook2-488. Microtubule polarity is
marked with minus (–) and plus (+).
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region for the interaction between KIF1C and Hook3, we purified
KIF1CΔ794-807 with carboxy-terminal SNAP tags and 3xFLAG tags
from 293T cells (Fig. S2 A) and labeled it with TMR via its SNAP
tag. Purified KIF1CΔ794-807 showed similar motile properties to
wild-type KIF1C in a single-molecule assay (Fig. S2, B–D; and
Video 3). However, when KIF1CΔ794-807-TMRwas incubated with
Hook3-488 and imaged using two-color TIRF microscopy, we
observed no colocalized events, further demonstrating the im-
portance of this region for Hook3 binding (Fig. 3 C and Video 4).
We also made point mutations within this 14-aa region, but were
unable to further refine the Hook3-binding site on KIF1C (Fig. S2
E). Taken together, our domain mapping identified a 14-aa re-
gion in the KIF1C tail that is necessary for Hook3 binding.
Next, we set out to map KIF1C’s binding site on Hook3. We
previously showed that the carboxy-terminal region of Hook3
(aa 553–718) is required for the KIF1C interaction (Redwine et al.,
2017). To attempt to map this binding site more precisely, we
generated a series of constructs lacking various regions in the
carboxy-terminal tail of Hook3. However, these constructs failed
to identify a single linear binding site (Fig. S2 F), perhaps be-
cause the KIF1C-binding site on Hook3 requires a folded domain.
As an alternative approach to generate a Hook3 construct that
could no longer bind KIF1C, we designed a chimeric construct in
which we replaced aa 553–718 of the Halo-Hook3-3xFLAG con-
struct with the homologous region of Hook2 (aa 548–719; Fig. 3 D
and Fig. S2 G), which we showed could not bind KIF1C (Fig. 1 F).
We then transfected this chimeric construct (Hook3Hook2),
full-length Hook3, Hook3 lacking the carboxy-terminal region
(Hook3NT), or Hook3 lacking the amino-terminal region (Hook3CT)
into 293T cells and performed FLAG immunoprecipitations. Only
full-length Hook3 or Hook3CT coimmunoprecipitated with en-
dogenous KIF1C (Fig. 3 E). To verify that this chimeric Hook3Hook2
construct does not directly interact with KIF1C, we purified it from
insect cells (Fig. S2 H) and labeled it with Alexa Fluor 488 via its
HaloTag. Using two-color TIRF microscopy, we showed that the
Hook3Hook2 chimera does not colocalize with KIF1C-TMR in a
single-molecule motility assay (Fig. 3 F and Video 5).
Purified full-length Hook3 is a robust dynein-activating
adaptor
Having shown that Hook3 and KIF1C directly interact, we next
tested the dynein-activating ability of Hook3 in an in vitro
system. Hook3 is a well-established dynein-activating adaptor
(McKenney et al., 2014). However, in vitro studies are limited to
analyses with a purified truncated version of Hook3 (aa 1–552,
Hook3NT) or full-length Hook3 present in cell lysates (Olenick
et al., 2016), rather than purified full-length protein. In addition,
since full-length BicD2, another dynein-activating adaptor, ex-
ists in an autoinhibited state (Stuurman et al., 1999; Hoogenraad
et al., 2001), we aimed to characterize the dynein activation
properties of purified full-length Hook3 and establish if full-
length Hook3 is autoinhibited.
To do so, we purified human dynein and dynactin complexes
separately from stable 293T cell lines expressing the dynein
intermediate chain (IC2) or the dynactin subunit p62 tagged
with the SNAP tag or HaloTag, respectively, and a 3xFLAG tag
(Redwine et al., 2017). We labeled IC2 with Alexa Fluor 647 and
used nonfluorescently labeled dynactin for these experiments.
In the absence of Hook3, the dynein/dynactin complex is largely
stationary in single-molecule motility assays, exhibiting occa-
sional diffusive events and very rare motile events (Fig. S3 A). In
the absence of dynein, Hook3 and dynactin are not motile (Fig.
S3 B). However, the combination of dynein, dynactin, and pu-
rified full-length Hook3 led to robust activation of dynein mo-
tility towardmicrotubule minus ends (Fig. 4 A and Video 6). The
velocity (0.658 ± 0.287 µm/s; Fig. 4 B) and run length (21.65 µm;
Fig. 4 C) were comparable to the values we obtained with
truncated Hook3NT (Fig. 4, D–F) and were also consistent with
previously reported values for truncated Hook3 (McKenney
et al., 2014; Schroeder and Vale, 2016; Redwine et al., 2017) or
Hook3 present in cell lysates (Olenick et al., 2016). In addition,
the chimeric Hook3Hook2 construct that does not bind KIF1C
(Fig. 3, E and F) activated dynein/dynactin to a similar extent as
full-length Hook3 (Fig. 4, G–I). Our analysis also showed that
dynein/dynactin activated by Hook3 displayed no difference in
pausing frequency or the number of processive, diffusive, or
static events (Fig. S3, D and E). This suggests that purified full-
length Hook3 is a robust dynein activator and is not auto-
inhibited in its native state.
Hook3 is a scaffold for dynein/dynactin and KIF1C
Thus far, our experiments indicate that full-length Hook3
directly associates with KIF1C and binds to and activates
dynein/dynactin complexes. We next sought to determine if
Hook3 could bind KIF1C and the dynein/dynactin complex
simultaneously. To test this, we performed three-color TIRF
microscopy experiments with purified proteins. For these
experiments, IC2 was labeled with Alexa Fluor 647, Hook3
with Alexa Fluor 488, and KIF1C with TMR, and dynactin was
unlabeled. This experimental setup allowed us to detect
moving events corresponding to (1) KIF1C alone, (2) KIF1C
with Hook3, (3) dynein/dynactin with Hook3, and (4) KIF1C
with dynein/dynactin and Hook3 (Fig. 5 A). The presence of
dynactin is inferred because it is required for dynein motility
(McKenney et al., 2014; Schlager et al., 2014). Complexes that
contained all three labeled components (dynein-647, Hook3-
488, and KIF1C-TMR) moved in either the minus end (Fig. 5 B,
top panel) or plus end (Fig. 5 B, bottom panel) directions
(Videos 7 and 8). The presence of these three-color colocalized
events implies that Hook3 scaffolds dynein/dynactin and
KIF1C to form a complex capable of moving toward the mi-
crotubule plus end or minus end. We did not observe three-
color colocalized runs when Hook3 was omitted from the
mixture (Fig. S4 A) or when TMR-labeled KIF1CΔ794-807 (Fig.
S4 B) or Alexa Fluor 488–labeled Hook3Hook2 (Fig. S4 C) was
used as opposed to their full-length wild-type counterparts.
Next, we quantified the velocity and run length of each de-
tectable species (Fig. 5 C and Fig. S4, D and E). Complexes con-
taining KIF1C and dynein/dynactin scaffolded by Hook3 had
slower velocities in the minus end direction compared with
complexes lacking KIF1C (Fig. 5 C). The slowing of the scaffolded
complexes in the minus end direction suggests that KIF1C may
engage the microtubule when dynein is the primary driver of
motility. Notably, we did not observe any runs (71 of 856 runs
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contained both motors) in which the moving molecules changed
direction.
Because we observed more minus end– versus plus end–
directed runs when both KIF1C and dynein were present in the
moving complexes (Fig. 5 D), wewondered if the number of runs
in either direction was dictated by the amount of each motor
available for Hook3 binding. To test this, we varied that relative
ratio of KIF1C to dynein in our experiments. These experiments
were performed with labeled dynein (Alexa Fluor 647) and
Hook3 (Alexa Fluor 488), and unlabeled dynactin and KIF1C. We
did not label KIF1C so that we could increase its concentration
and still observe single-molecule events. Due to the lack of a
label on KIF1C, we could detect three separate moving events: (1)
plus end–directed runs that were only Hook3/KIF1C, (2) plus
end–directed runs that contained both dynein and KIF1C, and (3)
minus end–directed runs that contained two species, dynein/
dynactin/Hook3 and dynein/dynactin/Hook3 with KIF1C. As the
KIF1C concentration was increased relative to dynein, we ob-
served an increase in the percentage of plus end–directed runs
containing both dynein and KIF1C, as well as the number of
Figure 4. Purified full-length Hook3 activates dynein motility. (A) Representative kymographs from single-molecule motility assays with purified dynein-
647 (green), unlabeled dynactin, and full-length Hook3-488 (magenta). Microtubule polarity is marked with minus (–) and plus (+). (B) A histogram of dynein/
dynactin velocity in the presence of purified full-length Hook3 fit to a Gaussian (black line, 0.658 ± 0.287 µm/s, mean ± SD, r2 = 0.910). Representative data
from three independent experiments are shown (n = 166). (C) Run length analysis of dynein/dynactin in the presence of full-length Hook3. The 1-cumulative
frequency distribution (green line) was fit to a one-phase exponential decay (black line). The representative mean decay constant is 21.65 µm (r2 = 0.902,
n = 133). (D) Representative kymographs from single-molecule motility assays with purified dynein-647 (green), unlabeled dynactin, and Hook31-552-488
(magenta). Microtubule polarity is marked with minus (–) and plus (+). (E) A histogram of dynein/dynactin velocity in the presence of Hook31-552 fit to a
Gaussian (black line, 0.710 ± 0.340 µm/s, mean ± SD, r2 = 0.931). Representative data from two independent experiments are shown (n = 158). (F) Run
length analysis of dynein/dynactin in the presence of Hook31-552. The 1-cumulative frequency distribution (green line) was fit to a one-phase exponential
decay (black line). The representative mean decay constant is 17.08 µm (r2 = 0.938, n = 118). (G) Representative kymographs from single-molecule
motility assays with purified dynein-647 (green), unlabeled dynactin, and the Hook3Hook2-488 chimera (magenta). Microtubule polarity is marked with
minus (–) and plus (+). (H) A histogram of velocity of dynein/dynactin in the presence of the Hook3HOOK2 chimera fit to a Gaussian (black line, 0.606 ±
0.345 µm/s, mean ± SD, r2 = 0.813). Representative data from three independent experiments are shown (n = 122). (I) Run length analysis of dynein/
dynactin in the presence of the Hook3Hook2-488 chimera. The 1-cumulative frequency distribution (green line) was fit to a one-phase exponential decay
(black line). The representative mean decay constant is 21.25 µm (r2 = 0.934, n = 139).
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Hook3/KIF1C runs. We also observed a corresponding decrease
in the percentage of minus end–directed runs (Fig. 5 E). Overall
these results imply that the binding of dynein and KIF1C to
Hook3 could be competitive. Velocity and run length analyses of
these events were comparable to the values we obtained in the
three-color experiments (Fig. 5 C and Fig. S4, D–I). These data
suggest that Hook3 might have different affinities for each
motor. In cells, this could result in differences in complex for-
mation or directionality depending on local cellular concen-
trations of each motor.
Figure 5. Hook3 is a scaffold for opposite-polarity motors. (A) Schematic of the experimental set up for three-color single-molecule motility assays. Four
different species are detectable using three-color imaging: (1) KIF1C-TMR (KIF1C), (2) KIF1C-TMRwith Hook3-488 (KIF1C/Hook3), (3) dynein-647 with dynactin
and Hook3-488 (DDH), and (4) dynein-647 with dynactin, Hook3-488, and KIF1C-TMR (DDHK). (B) Representative kymographs from single-molecule motility
assays with purified dynein-647, unlabeled dynactin, KIF1C-TMR, and Hook3-488. A three-color colocalized minus end–directed run (top panel) and three-color
colocalized plus end–directed run (bottom panel) are marked with white arrows on each single-channel image and in the merge. The yellow signal in the merge
highlights the colocalized run. Microtubule polarity is marked with minus (–) and plus (+). (C) Velocity analysis of the indicated complexes (KIF1C, n = 345;
KIF1C/Hook3, n = 136; DDHK+, n = 18; DDH, n = 304; DDHK−, n = 53). Statistical significance was calculated with a one-way ANOVAwith Tukey post-test; *, P =
0.0121. Combined data from four independent experiments is shown. (D) Percent processive events (mean ± SEM) reported in C. Combined data from four
independent experiments is shown. (E) Percent processive events (mean ± SEM) in the two-color assay with purified dynein-647, unlabeled dynactin, Hook3-
488, and unlabeled KIF1C. Increasing concentrations of unlabeled KIF1C are used as indicated by the dynein:KIF1C ratio. Combined data from three independent
experiments is shown.
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KIF1C recruits Hook3 to the cell periphery
Thus far, our data indicate that Hook3 and KIF1C directly in-
teract and that Hook3 can scaffold complexes containing both
dynein/dynactin and kinesin. We next explored whether these
interactions take place in a cellular context. To test this, we took
advantage of our KIF1C 293T knockout cells (Fig. 1 B). We in-
fected KIF1CKO cells (clone #1) with MSCV-driven retroviral
KIF1C-tagRFP or KIF1CΔ794-807-tagRFP plasmids to generate sta-
ble cells expressing exogenous KIF1C-tagged proteins and used
confocal immunofluorescence microscopy to image the cells.
Although the KIF1C-tagRFP or KIF1CΔ794-807-tagRFP protein ex-
pression levels in these cells were higher than in control
293T cells, this approach allowed us to account for the complete
pool of KIF1C in the cell (Fig. 6 A). KIF1C knockout in these cells
did not alter Hook3’s localization (Fig. S5 A). However, full-
length wild-type KIF1C recruited endogenous Hook3 to the cell
periphery, and this recruitment was abolished in cells express-
ing KIF1C lacking the Hook3 binding region (Fig. 6, B and C). We
also tested if dynactin was recruited to the cell periphery in a
KIF1C-dependent manner, but did not observe relocalization of
dynactin (Fig. S5, B and C).
Next, we asked if the KIF1C-binding region on Hook3 was
required for KIF1C-dependent recruitment of Hook3 to the cell
periphery. To do this, we cotransfected human U2OS cells with
Hook3 (tagged with super folder GFP [sfGFP]) and KIF1C (tagged
with V5) plasmids and visualized their localization using con-
focal immunofluorescence microscopy. sfGFP alone or sfGFP
tagged Hook3 constructs, including full-length Hook3, Hook3NT,
and Hook3CT, where expressed in U2OS cells in the presence or
absence of KIF1C. Expression of these constructs alone in U2OS
cells led to mainly cytoplasmic Hook3 localization, similar to
endogenous Hook3 distribution in these cells (Fig. S5, D and E).
However, when KIF1C was coexpressed with Hook3 or Hook3CT,
Hook3 was enriched in KIF1C-V5 foci found at the cell periphery
(Fig. 6, D and E). This enrichment was lost when Hook3NT,
which lacks the KIF1C-binding region, was coexpressed with
KIF1C-V5 (Fig. 6, D and E). Together our data show that KIF1C
recruits Hook3 to the cell periphery and that this recruitment
depends on the binding sites we identified in both KIF1C and
Hook3.
Discussion
Here we have shown that the dynein-activating adaptor Hook3
directly scaffolds the opposite-polarity motors cytoplasmic
dynein-1/dynactin and the kinesin KIF1C. In doing so, we have
reported the single-molecule motile properties of KIF1C in the
presence and absence of full-length Hook3. We mapped the
Hook3 interacting region on KIF1C to 14 aa in its tail. Hook3 and
KIF1C also interact in a cellular environment, as KIF1C recruits
Hook3 to the cell periphery. Full-length Hook3 does not activate
the motile properties of KIF1C, but is required to activate dyn-
ein/dynactin motility. Finally, we reconstituted the entire dyn-
ein/dynactin/Hook3 and KIF1C complex from pure components
and characterized its motile properties. While complexes con-
taining both motors are relatively rare, we show that dynein/
dynactin can transport KIF1C and KIF1C can transport dynein.
KIF1C is a highly processive motor whose activity is not
activated by Hook3
Under our analysis conditions, full-length KIF1C is a highly
processive motor with a characteristic run length that is >15 µm.
Kinesin-1s are regulated by autoinhibition via interactions be-
tween their motor and tail domains (Friedman and Vale, 1999;
Stock et al., 1999; Hackney and Stock, 2000). Several lines of
evidence suggest that dimeric kinesin-3 familymembers are also
autoinhibited (Yamada et al., 2007; Hammond et al., 2009;
Farkhondeh et al., 2015). The fact that our purified full-length
KIF1C alone is a robust processive motor may indicate that it is
not autoinhibited. It is also possible that KIF1C as purified from
human 293T cells contains posttranslational modifications that
could relieve autoinhibition. High-throughput proteomics ap-
proaches suggest that KIF1C is phosphorylated, as well as mono-
methylated, inmultiple regions in its tail (Hornbeck et al., 2015).
However, how phosphorylation or other candidate posttransla-
tional modifications affect KIF1C’s motor activity has not been
investigated. In our experiments, the addition of Hook3 had no
effect on KIF1C’s velocity, pausing frequency, or landing fre-
quency, and caused a modest decrease in KIF1C’s run length.
This suggests that Hook3 is not required to activate KIF1C mo-
tility, but rather that Hook3 may function to link KIF1C to other
proteins or cargos. In addition, our data suggest that KIF1C exists
as a dimer in the presence or absence of Hook3. It is likely that
KIF1C interacts with a Hook3 homodimer based on previous
evidence showing that Hook proteins, as well as other dynein-
activating adaptors, form dimers alone or when in a complex
with dynein/dynactin (Urnavicius et al., 2015; Schroeder and
Vale, 2016; Lee et al., 2018).
Simultaneous with our work, another group reported the
motile properties of KIF1C (Siddiqui et al., 2019). In that study,
KIF1C purified from insect cells appeared to be largely inactive
as observed by single-molecule motility experiments. The ad-
dition of Hook3 or deletion of a region of KIF1C’s third predicted
coiled-coil domain increased the landing rate of KIF1C. In con-
trast, we did not observe a difference in landing rate in the
presence of Hook3. The differences between our results and that
work (Siddiqui et al., 2019) could be due to the source of the
protein, posttranslational state of the protein, purification
methods, or motility assay conditions. Further work will be re-
quired to differentiate among these possibilities.
Hook3 is a scaffold for bidirectional motility
Our three-color single-molecule experiments show that Hook3,
KIF1C, and dynein/dynactin can exist in a complex together.
Furthermore, complex formation requires the KIF1C binding site
we identified, and the complex does not form when the carboxy
terminus of Hook3 is replaced by the carboxy terminus of Hook2
(the Hook family member we showed did not bind KIF1C). Our
analysis of fully reconstituted dynein/dynactin/Hook3 and
KIF1C complexes indicates that KIF1C can transport dynein/dy-
nactin toward microtubule plus ends and that dynein/dynactin
can transport KIF1C toward microtubule minus ends. This sug-
gests that opposite-polarity motor binding to Hook3 is not mu-
tually exclusive. Simultaneous Hook3 binding to both motors
negatively affects dynein’s motility. At the concentrations used
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Figure 6. KIF1C recruits Hook3 to the cell periphery. (A) 293T KIF1CKO cells (KO) were infectedwith viral particles encodingMSCV-driven KIF1C-tagRFP-3xFLAG
or KIF1CΔ794-807-tagRFP-3xFLAG plasmids. Immunoblots were performed with the indicated antibodies. Low and high exposures with the KIF1C antibody are shown.
β-Actin provided a loading control. 293T cells transfected with CRISPR-Cas9 (CTRL) were used as control cells. (B) Confocal microscopy of KIF1C and Hook3 localization
in stable 293T cell lines expressing KIF1C-tagRFP-3xFLAG or KIF1CΔ794-807-tagRFP-3xFLAG. Cells were grown on glass coverslips, fixed, and stained for endogenous
Hook3 (Endo-Hook3). The tagRFP and Hook3 signals are shown in representative maximum intensity projections. The overlap of intensity profiles (AU) generated from
drawing a 15-µm line segment across individual z-sections is shown to the right of the images. (C) The mean normalized Hook3 intensity within KIF1C foci for KIF1C-
tagRFP-3xFLAG (n = 25) or KIF1CΔ794-807-tagRFP-3xFLAG (n = 24). Foci were determined by thresholding the KIF1C image, andmasks of these foci were used tomeasure
the Hook3 intensity in the corresponding regions in maximum projection images. Box plots represent the maximum and minimum values. Statistical significance was
calculatedwith an unpaired t test. ****, P < 0.0001. Representative data from three independent experiments is shown. (D) Confocal microscopy of KIF1C andHook3 in
U2OS cells. Cells were grown on glass coverslips and transiently cotransfected with the indicated sfGFP-tagged Hook3 (full-length Hook3, Hook3NT [aa 1–552], and
Hook3CT [aa 553–718]) or control sfGFP constructs, and KIF1C-V5. 24 h after transfections, cells were fixed and stained with V5-specific antibody. The V5 and sfGFP
signals are shown in representative maximum intensity projections. The overlap of intensity profiles (AU) generated from drawing a 15-µm line segment across an
individual z-section is shown to the right of the images. (E) Themean normalized Hook3 intensity within KIF1C foci for cells transfected with different Hook3 constructs
(CTRL, n = 27; Hook3, n = 28; Hook3NT, n = 33; Hook3CT, n = 29). Foci were determined by thresholding the KIF1C image, andmasks of these foci were used to measure
the Hook3 intensity in these corresponding regions in maximum projection images. Box plots represent maximum and minimum values. Statistical significance was
calculated with one-way ANOVA with Tukey post-test, ****, P < 0.0001. Representative data from three independent experiments is shown. ns, not significant.
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in our assays, it appears that a higher fraction of Hook3 as-
sociates with dynein than with KIF1C, which could indicate
that Hook3 has a higher affinity for dynein than for KIF1C. Our
analysis raises the possibility that dynein and KIF1C may
compete for Hook3 binding. We also note that complexes
containing both motors are relatively rare, suggesting that
interaction of Hook3 with each motor could be regulated in
cells. A detailed analysis of various binding affinities and
complex stoichiometry will require higher purification yields
of all components.
We do not observe any switches in direction, but we do ob-
serve that the presence of KIF1C can slow the velocity of dynein/
dynactin/Hook3 complexes in the minus end direction. This is
consistent with a model in which KIF1C engages microtubules
while being pulled by dynein toward microtubule minus ends,
thus slowing dynein’s velocity. Similar velocity decreases have
been observed with other opposite-polarity motor teams (Derr
et al., 2012; Roberts et al., 2014; Belyy et al., 2016). Our data
suggest that if dynein and KIF1C share a common cargo that
moves bidirectionally, the activity of each motor type may be
regulated to achieve changes in direction. If such factors exist,
our reconstituted system is likely missing them as indicated by
the lack of directional switching of dynein/dynactin/Hook3/
KIF1C complexes and the purity of our components.
What is the physiological function of kinesin and dynein/
dynactin complexes scaffolded by Hook3?
Our data do not directly determine the physiological role of
dynein/dynactin complexes scaffolded to KIF1C by Hook3;
however, our experiments and others in the literature suggest
several possibilities, all of which will be exciting areas for future
research.
First, it is possible that Hook3 scaffolds KIF1C and cytoplas-
mic dynein for the bidirectional motility of a shared cargos.
Consistent with this, KIF1C cargos move bidirectionally in hu-
man epithelial cells and neurons (Schlager et al., 2010; Theisen
et al., 2012). Multiple cargos for KIF1C have been proposed.
KIF1C is implicated in the transport of α5β1-integrins for focal
adhesion and podosome formation (Kopp et al., 2006; Theisen
et al., 2012; Efimova et al., 2014). KIF1C has also been shown to
bind to Rab6 (Lee et al., 2015), and KIF1C depletion leads to
defects in synaptic vesicle transport (Schlager et al., 2014; Lipka
et al., 2016). In contrast, the most likely cargos for Hook3 are
endo-lysosomal compartments (Guo et al., 2016). Hook3 is part
of the FHF complex, named after its components, Fused-Toes
homologue (FTS), Hook-related protein, and FTS and Hook-
interacting protein (FHIP; Xu et al., 2008; Bielska et al., 2014;
Yao et al., 2014). FHF is thought to link the dynein/dynactin
complex to Rab5-marked early endosomes, which move bidi-
rectionally in both neurons and filamentous fungi (Bielska et al.,
2014; Yao et al., 2014; Zhang et al., 2014; Guo et al., 2016).
Second, the functional role of Hook3 in scaffolding dynein
and KIF1C could be to recycle one or both motors. Such recycling
of dynein by kinesin has been observed in Saccharomyces cer-
evisiae, where dynein is transported to microtubule plus ends by
a kinesin and a set of accessory proteins (Moore et al., 2009).
This process is through direct protein–protein interactions, as it
has been reconstituted in vitro (Roberts et al., 2014). In addition,
in Drosophila melanogaster oocytes, filamentous fungi, and neu-
rons, kinesin-1 family members are required for dynein’s plus
end localization (Brendza et al., 2002; Zhang et al., 2003;
Twelvetrees et al., 2016). If and how kinesins are recycled are
less clear; one study of mammalian kinesin-1 suggests that dif-
fusion is sufficient for its recycling (Blasius et al., 2013).
Finally, a third possible function of this complex could be to
sequester Hook3 from the available pool of dynein/dynactin
activating adaptors. Our cellular analysis shows that KIF1C re-
cruits Hook3 to the cell periphery in a manner that depends on
the binding sites we identified in both KIF1C and Hook3. By
removing Hook3 from the cellular pool of dynein activators,
KIF1C could be acting as a negative regulator of dynein/dy-
nactin/Hook3 cargo motility. Our observation that KIF1C does
not recruit dynactin to the cell periphery supports this possi-
bility, at least in 293T cells.
Is scaffolding of dynein/dynactin and kinesin by
dynein-activating adaptors a general principle?
We have directly demonstrated that the dynein-activating
adaptor Hook3 scaffolds KIF1C and dynein/dynactin and that
these complexes can move toward either the plus end or the
minus end of microtubules. Do other dynein-activating adaptors
perform similar functions for dynein/dynactin and other kine-
sins? There are hints in the literature that this may be the case.
For example, interactions between KIF1C and both BicD2 and
BicDL1 have also been suggested. In the case of BicD2, network
analysis of genes mutated in hereditary spastic paraplegias, a
disease associated with KIF1C mutations (Dor et al., 2014),
identified BicD2 as a possible KIF1C interactor (Novarino et al.,
2014). This interaction was confirmed by coimmunoprecipita-
tion with overexpressed proteins (Novarino et al., 2014). In the
case of BicDL1, it was shown to interact with KIF1C via two-
hybrid experiments and endogenous KIF1C coimmunoprecipi-
tated with overexpressed BicDL1 (Schlager et al., 2010). Other
proteins that share a similar general domain structure to the
bona fide dynein activating adaptors, such as TRAK1, TRAK2,
and HAP1, are candidate dynein-activating adaptors (Reck-
Peterson et al., 2018). Interestingly, TRAK1, TRAK2, and HAP1
have all been shown to interact with kinesin-1 family members
and dynein/dynactin subunits (Engelender et al., 1997; Li et al.,
1998; Twelvetrees et al., 2010; van Spronsen et al., 2013). Cell
biological and in vitro reconstitution experiments will be re-
quired to determine if these candidate dynein-activating adap-
tors and other known dynein-activating adaptors scaffold
dynein/dynactin to kinesin family members for bidirectional
motility.
Materials and methods
Molecular cloning
All plasmids used in this study, unless otherwise stated, were
constructed by PCR and Gibson isothermal assembly. BioID G2
(Kim et al., 2014) was a gift of K. Roux (Sanford School of
Medicine, University of South Dakota, Vermillion, SD). P62
(isoform 1, 460 aa) was amplified from a human RPE1 cell cDNA
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library (generated in the Reck-Peterson laboratory). Hook3
(clone ID: 5106726), KIF1A (clone ID: 40037561), KIF1B (clone ID:
319918), KIF5A (clone ID: 40148192), KIF5B (clone ID: 8991995),
and KIF5C (clone ID: 516562) cDNAs were obtained from
Dharmacon. Hook1 (clone ID: HsCD00044030), Hook2 iso-
form 2 (clone ID: HsCD00326811), and KIF1C (clone ID:
HsCD00336693) cDNAs were obtained from PlasmidID
(Harvard Medical School, Boston, MA). Hook2 isoform
2 clone was mutagenized in the Reck-Peterson laboratory to
generate Hook2 isoform 1. The Hook3Hook2 chimera construct
was generated by replacing Hook3 aa 553–718 with Hook2 aa
548–719 using Gibson isothermal assembly and cloned into pLIB
vector containing an amino-terminal His6-ZZ-TEV-HaloTag for
expression in Sf9 cells. The pSpCas9(BB)-2A-Puro (PX459) V2.0
vector was a gift from F. Zhang (Broad Institute, Cambridge,
MA; plasmid 62988; Addgene).
Cell lines and transfections
Human 293T and U2OS cells were obtained from ATCC and
maintained at 37°C with 5% CO2 in DMEM (Corning) supple-
mented with 10% FBS (Gibco) and 1% penicillin streptomycin
(PenStrep; Corning). Sf9 cells were obtained from Thermo
Fisher Scientific and grown in Sf-900 II SFM media (Thermo
Fisher Scientific). All cells were routinely tested for myco-
plasma contamination and were not authenticated after
purchase.
CRISPR/Cas9-mediated genome editing
Gene editing for creation of KIF1C cells was performed as
described previously (Ran et al., 2013). Briefly, in vitro–
transcribed 20-nucleotide Alt-R CRISPR RNA (CrRNA,
Hs.Cas9.KIF1C.1.AD) and Alt-R CRISPR/Cas9 trans-activating
CRISPR RNA (tracrRNA) were purchased from Integrated
DNA Technologies. The KIF1C exon 3 crRNA sequence
was 59-TCTCACTAACGCGAGAGAAG-39. To prepare the Alt-R
crRNA and Alt-R tracrRNA duplex, reconstituted oligos
(100 µM) were mixed at equimolar concentrations in sterile
PCR water and annealed at 95°C for 5 min, followed by slow
cooling to room temperature. To generate knockout cells,
200 ng of pX459 vector and KIF1C crRNA-tracrRNA duplex
(10 nM) were diluted in OptiMEM (Gibco) and combined with
1 µg/µl polyethylenimine (PEI; Polysciences Inc.) in a 4:1 ratio
of PEI:DNA for transfection into 293T cells. 48 h after trans-
fection, the cells were pulsed with 1 μg/ml puromycin for 24 h
to allow selection of pX459-transfected cells. Following puro-
mycin selection and recovery in DMEM without puromycin,
single-cell clones were plated in 96-well format by limiting
dilution and cultured to allow single colonies to grow out.
Clones were expanded to 12-well plates, and samples of re-
sulting clones were screened via immunoblotting with two
independent gene-specific antibodies (KIF1C, rabbit polyclonal
Novus No. NBP1-85978, immunogen from aa 996–1096, and
rabbit polyclonal, Thermo Fisher Scientific No. PA5-27657,
immunogen from aa 452–758). A SURVEYOR mutation detec-
tion kit (706020; Integrated DNA Technologies) was used to
detect KIF1C-edited clones.
Stable cell lines with near-endogenous protein expression
generation
KIF1CKO clones were reconstituted with near-endogenous
KIF1C-BioID-3xFLAG, KIF1C-tagRFP-3xFLAG, or KIF1CΔ794-807-
tagRFP-3xFLAG, respectively, using a retroviral infection/
MSCV-driven expression system as described previously
(Sowa et al., 2009). Briefly, plasmid DNA (retroviral pMSCV
with KIF1C-3xFLAG-BioID, BioID-3xFLAG, KIF1C-tagRFP-
3xFLAG, and KIF1CΔ794-807-tagRFP-3xFLAG genes inserted)
along with viral helper constructs (retroviral MSCV-vsvg,
MSCV-gag/pol) were diluted in OptiMEM (Gibco) and com-
bined with 1 µg/µl PEI (Polysciences Inc.) in a 3:1 ratio of PEI:
DNA concentration. The transfection mixture was added to
293T cells, followed by incubation for 12–16 h. Fresh DMEMwas
added to the cells, followed by a 24-h incubation to allow virus
production. Viral supernatant was collected, filtered, and added
to recipient 293T cells along with 1 µg/ml polybrene (Sigma-
Aldrich) for infection. Stable cell lines were established by
puromycin selection (0.75 µg/ml) for 48–72 h. Expression of
exogenous proteins was confirmed via immunoblotting with
anti-KIF1C and anti-FLAG M2-HRP antibodies.
FLP/FRT stable cell line generation
Dynein (IC2-SNAPf-3xFLAG), dynactin (p62-Halo-3xFLAG), ki-
nesin (KIF1A, KIF1B, KIF1C, KIF5A, KIF5B, and KIF5C), carboxy-
terminal BIoID-3xFLAG, and BioID-3xFLAG stable cell lines were
created with the FLP/FRT system and T-Rex 293T cells (In-
vitrogen). These lines were generated as previously described
(Redwine et al., 2017). Briefly, 1 d before transfection cells were
plated onto 10-cm dishes. Cells were transfected with 30 µl
of Lipofectamine 2000 and a combination of the appropriate
pcDNA5/FRT/GOI construct and Flipase-expressing pOG44
plasmid (5 µg of total DNA: nine parts pOG44 + one part
pcDNA5/FRT/GOI). After a 24-h recovery, cells were grown in
DMEM containing 10% FBS, 1% PenStrep, and 50 µg/ml Hy-
gromycin B. Colonies were isolated, expanded, and screened for
expression of the fusion proteins by immunoblotting with an
anti-FLAG M2-HRP antibody.
Transient transfections
For small-scale immunoprecipitations from transiently trans-
fected 293T cells, 1.5 × 106 cells were plated onto a 10-cm dish
1 d before transfection. Transfections were performed with
PEI and 2 µg of transfection-grade DNA (Purelink midi prep
kit; Invitrogen) per dish, with the exception of Halo-Hook3NT-
3xFLAG, where 1 µg of DNA was used due to high-protein
expression if higher amounts of DNA were used. After 24 h,
the media was exchanged to fresh DMEM containing 10% FBS
and 1% PenStrep. Cells were then grown for an additional 24 h
before lysate preparation. For large-scale protein purifica-
tions, 293T cells were plated onto 30 × 15-cm dishes and
grown to ∼50% confluence. Cells were transiently transfected
with PEI and 7.5 µg DNA per plate. The PEI/DNA mixture was
added to plates containing fresh DMEM + 10% FBS (no anti-
biotics) and incubated overnight. The following day, the cells
were split 1:3 into 90 × 15-cm plates and incubated an addi-
tional 24 h. Cells were collected by pipetting with ice-cold 1×
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PBS, pH 7.4, centrifuged, and washed twice with 1× PBS. The
cells were flash-frozen in liquid nitrogen before lysis.
For immunofluorescence, 0.01–0.03 × 106 cells were plated
onto fibronectin (0.001%; Sigma-Aldrich) coated glass cover-
slips in 24-well plates and grown for 24 h. The next day,
transfections were performed with Lipofectamine 2000 and
0.5 µg DNA per well. The Lipofectamine/DNA mixture was
added to wells containing fresh DMEM + 10% FBS (no anti-
biotics) and incubated overnight. The following day, cells
were fixed and stained.
Immunoprecipitations
Immunoprecipitation from transiently transfected cells
Transiently transfected cells were collected by decanting the
media and washing the cells off the dish with ice-cold 1× PBS.
Cells were collected by centrifugation at 1,000 × g for 3 min,
washed again with 1× PBS, and then transferred with 1× PBS to
Eppendorf tubes for lysis. After spinning at 2,000 rpm in a
microcentrifuge for 4 min and removing the 1× PBS, cells were
flash-frozen for storage or immediately lysed in 500 µl of dynein
lysis buffer (DLB; 30 mM Hepes, pH 7.4, 50 mM KOAc, 2 mM
MgOAc, 1 mM EGTA, pH 7.5, and 10% glycerol) supplemented
with 1 mM DTT, 0.2% Triton X-100, and 1× protease inhibitor
cocktail (cOmplete Protease Inhibitor Cocktail; Roche) with
gentle mixing at 4°C for 20 min. Lysates were then centrifuged
at maximum speed in a 4°C microcentrifuge for 15 min. For each
immunoprecipitation, 420 µl clarified lysate was retrieved and
added to 50 µl packed volume of anti-FLAG M2 agarose slurry
(Sigma-Aldrich) and incubated for 2 h at 4°C. Cells were washed
four times with 1 ml of DLB, and elutions were performed with
50 µl of DLB supplemented with 1 mg/ml 3xFLAG peptide
(ApexBio).
Immunoprecipitation of endogenous proteins
Wild-type 293T cells were grown to ∼75% confluence and col-
lected by pipetting with cold 1× PBS on ice. For each immuno-
precipitation, a single 15-cm plate was collected, washed, and
resuspended in 1 ml of DLB supplemented with 1 mM DTT, 0.2%
Triton X-100, and 1× protease inhibitor cocktail (cOmplete
Protease Inhibitor Cocktail; Roche). Resuspended cells were
gently mixed at 4°C for 15 min, and then centrifuged at maxi-
mum speed in a 4°C microcentrifuge. The beads were prepared
by incubating appropriate antibodies with Dynabeads Protein G
(Thermo Fisher Scientific). For each immunoprecipitation
sample, 100 µl of bead slurry was washed three times with
500 µl of 1× PBS and then resuspended in 100 µl of 1× PBS. To
this mixture, 4 µg of the appropriate antibody was added
(Hook3; ProteinTech No. 15457–1-AP, immunogen full-length
protein; KIF1C, Bethyl No. A301-070A, immunogen from aa
900–950; Normal Rabbit IgG, Cell Signaling Technology No.
2729) and incubated for 30 min at room temperature. The resin
was washed twice with 1× PBS and then once with DLB. After
removing the final wash, 1 ml of cell lysate was added to the
prepared resin and incubated for 4 h at 4°C. The beads were then
washed three times with 1 ml DLB. To elute proteins, the resin
was resuspended in 60 µl of 4× sample buffer and heated at 95°C
for 5 min. Eluted proteins were analyzed by SDS-PAGE followed
by immunoblotting.
Immunoblotting and antibodies
Lysates and eluates were run on 4–15% polyacrylamide gels
(NuPage; Invitrogen). Protein gels were transferred to poly-
vinylidene difluoride membranes for 1.5 h at 110 V (constant
voltage) at 4°C. The membranes were blocked with PBS +
0.05% Tween-20 (vol/vol) + 5% dry milk (wt/vol) and im-
munoblotted with the appropriate antibodies. All antibodies
were diluted in PBS + 0.05% Tween-20 + 1% milk (wt/vol).
Primary antibodies were incubated overnight at 4°C, while
secondary antibodies were incubated for 1 h at room tem-
perature. Immunoblots were visualized with Supersignal
West Pico Chemiluminescent reagent (Thermo Fisher Scien-
tific) or Supersignal West Femto Chemiluminescent reagent
(Thermo Fisher Scientific) on a VersaDoc imaging system
(BioRad). Image intensity histograms were adjusted in Image
Laboratory Version 6.0.1 (BioRad) and then imported into
Adobe Illustrator to make figures.
Antibodies used for immunoblots were as follows: anti-FLAG
M2-HRP (Sigma-Aldrich No. A8592; 1:5,000 dilution), anti-
KIF1C (Novus Biotechnologies No. NBP1-85978, immunogen
from aa 996–1096;1:500 dilution), anti-actin (Thermo Fisher
Scientific No. MAP-15739, immunogen: β-actin amino-terminal
peptide; 1:4,000 dilution), anti-Hook3 (ProteinTechNo. 15457–1-A,
immunogen: full-length protein; 1:1,000 dilution), goat anti-rabbit
HRP (Santa Cruz Biotechnology No. sc-2030; 1:4,000 dilution) and
goat anti-mouse HRP (Santa Cruz Biotechnology No. sc-2031;
1:4,000 dilution).
Immunofluorescence, confocal microscopy and image analysis
Fixation and staining
Cells of each condition were grown on fibronectin-coated glass
coverslips, transfected if indicated, and fixed with 4% PFA
(Thermo Fisher Scientific) in 1× PBS. Cells were washed with
PBS, then permeabilized and blocked with 5% normal goat se-
rum (Cell Signaling Technology) in PBS containing 0.5% Triton
X-100 (Sigma-Aldrich). Cells were immunostained overnight at
4°C with indicated antibodies diluted in PBS with 1% BSA
(Sigma-Aldrich) and 0.1% Triton X-100. The following day, cells
were washed with PBS and stained with appropriate secondary
antibodies and Alexa Fluor 647– or 488–conjugated phalloidin
(Invitrogen). Cells were then washed with PBS, and coverslips
were mounted on glass slides with CitiFluor AF1 mounting
media (TedPella).
Antibodies used for immunofluorescence were as follows:
anti-Hook3 (Thermos Fisher Scientific No. PA5-55172, im-
munogen full-length protein; 1:200 dilution), anti-dynactin
(p150, BD Bioscience No. 610473, immunogen from aa 3–202;
1:200 dilution), anti-V5 (Sigma-Aldrich, No. V8137; 1:1,000
dilution), goat anti-rabbit IgG (H+L) Alexa Fluor 568 (Thermo
Fisher Scientific No. A11036; 1:500 dilution), goat anti-rabbit
IgG (H+L) Alexa Fluor 488 (Thermo Fisher Scientific No.
A11008; 1:500 dilution), and goat anti-mouse IgG (H+L) Alexa
Fluor 647 (Thermo Fisher Scientific No. A28181; 1:500
dilution).
Kendrick et al. Journal of Cell Biology 2994
Hook3 is a scaffold for opposite-polarity motors https://doi.org/10.1083/jcb.201812170
Confocal microscopy
Cells were imaged using a Nikon A1R HD confocal microscope
with a four-line (405 nm, 488 nm, 561 nm, and 640 nm) LUN-V
laser engine and DU4 detector using bandpass and longpass fil-
ters for each channel (450/50, 525/50, 595/50, and 700/75),
mounted on a Nikon Ti2 using an Apo 100× 1.49 NA objective.
Image stacks were acquired in resonant mode with bidirectional
scanning and 2× or 4× line averaging. The lasers used were 405
nm, 488 nm, 561 nm, and 640 nm. To avoid cross-talk between
channels, z-stacks were acquired of the AlexaFluor 568 or
tagRFP channel first, and the sfGFP or Alexa Fluor 488 and Alexa
Fluor 647 channels were acquired subsequently. Illumination
and image acquisition was controlled by NIS Elements Advanced
Research software (Nikon Instruments).
Quantification of colocalization between KIF1C, Hook3,
and dynactin
The colocalization with KIF1C was measured with a multi-step
automated script assembled with the GA3 module within NIS
Elements (Nikon Instruments). In the first step, an intensity and
size threshold using the phalloidin or sfGFP channel was used to
map the area of the intracellular region. The intracellular region
was defined as all cells within the image containing KIF1C signal.
Then KIF1C-positive foci were identified by applying a second
threshold in the red channel based on fluorescence intensity and
size. Binary masks of the KIF1C-positive foci that were within
the intracellularmasks were selected, and the intensity of Hook3
or dynactin staining within the KIF1C foci and intracellular
binaries was measured. The average intensity of Hook3 or
dynactin under the KIF1C mask was then divided by the average
intensity of Hook3 or dynactin under the intracellular mask.
This normalized fluorescence intensity of Hook3 or dynactin
contained within the foci was then plotted for each condition.
For each condition, ≥30 cells were analyzed per experiment.
Data visualization and statistical analysis were performed using
GraphPad Prism (8.0d; GraphPad Software). Statistical analysis
was performed with unpaired t test and one-way ANOVA with
Tukey post-test. Maximum projection images of confocal
z-stacks and plot profiles of 15 µm lines drawn through indi-
vidual z-sections were generated in ImageJ (2.0) and imported
into Adobe Illustrator (version 21.0.1) to make figures. Bright-
ness and contrast of all representative images were adjusted in
ImageJ.
BioID sample preparation and MS
Cell growth and streptavidin purification
Growth of cells and sample preparation for BioID experiments
were performed as previously described with slight mod-
ifications (Redwine et al., 2017). Briefly, BioID-3xFLAG or
KIF1C-BioID-3xFLAG cells were plated at ∼20% confluence in
15-cm dishes as four replicates, with each replicate consisting
of 8 × 15-cm plates. After 24 h, biotin was added to the media
to a final concentration of 50 µM, and the cells were allowed to
grow for another 16 h. After decanting the media, cells were
dislodged from each plate by pipetting with ice-cold 1× PBS.
Cells were centrifuged at 1,000 × g for 2 min followed by two
washes with ice-cold 1× PBS, and the cell pellets were
resuspended and lysed in 16 ml RIPA buffer (50 mM Tris-HCl,
pH 8.0, 150 mM NaCl, 1% [vol/vol] NP-40, 0.5% [wt/vol] so-
dium deoxycholate, 0.1% [wt/vol] SDS, 1 mM DTT, and pro-
tease inhibitors [cOmplete Protease Inhibitor Cocktail;
Roche]) by gentle rocking for 15 min at 4°C. The cell lysate was
clarified via centrifugation at 66,000 × g for 30 min in a Ti70
rotor (Beckman Coulter) at 4°C. The clarified lysate was re-
trieved and combined with prewashed 0.8 ml streptavidin-
conjugated beads (Pierce Streptavidin magnetic beads) and
incubated overnight at 4°C with gentle rocking. Bead/lysate
mixtures were collected on a magnetic stand into a single 2-ml
round-bottom microcentrifuge tube. The beads were then
washed three times with 2-ml RIPA buffer and once with 1×
PBS with immobilization and solution removal performed on a
magnetic stand.
On-bead digestion
Samples were prepared for MS as follows. After the final
wash, the beads were resuspended in 100 µl of 50 mM am-
monium bicarbonate (Thermo Fisher Scientific), and the
proteins on the beads were reduced with 10 mM DTT for
30 min at room temperature and alkylated with 55 mM io-
doacetamide (Sigma-Aldrich) for 30 min in the dark. Protein
digestion was performed with sequencing grade modified
trypsin (Promega) at 1/50 protease/protein (wt/wt) at 37°C
overnight. After trypsin digestion, the beads were washed
twice with 100 µl of 80% acetonitrile (Thermo Fisher Scien-
tific) in 1% formic acid (Thermo Fisher Scientific), and the
supernatants were collected. Samples were dried in Speed-
Vac (Thermo Fisher Scientific) and desalted and concen-
trated on a C18 Tip (Thermo Fisher Scientific).
MS data acquisition
On-bead digested samples were analyzed on an Orbitrap Fu-
sion mass spectrometer (Thermo Fisher Scientific) coupled to
an Easy-nLC 1200 system (Thermo Fisher Scientific) through
a nanoelectrospray ion source. Peptides were separated on a
self-made C18 analytical column (100 µm internal diameter ×
20 cm length) packed with 2.7 µm Cortecs particles. After
equilibration with 3 µl 5% acetonitrile and 0.1% formic acid
mixture, the peptides were separated by a 120-min linear
gradient from 6 to 42% acetonitrile with 0.1% formic acid at
400 nl/min. Liquid chromatography (Optima LC/MS; Thermo
Fisher Scientific) mobile phase solvents and sample dilutions
were all made in 0.1% formic acid diluted in water (buffer A)
and 0.1% formic acid in 80% acetonitrile (buffer B). Data ac-
quisition was performed using the instrument-supplied Xca-
libur (version 4.1) software. Survey scans covering the mass
range of 350–1,800 were performed in the Orbitrap by scan-
ning from a mass/charge ratio (m/z) of 300–1800 with a
resolution of 120,000 (at m/z 200), an S-Lens RF Level of 30%,
a maximum injection time of 50 ms, and an automatic gain
control target value of 4 × 105. For MS2 scan triggering,
monoisotopic precursor selectifon was enabled, charge state
filtering was limited to 2–7, an intensity threshold of 2 × 104
was used, and dynamic exclusion of previously selected
masses was enabled for 45 s with a tolerance of 10 ppm. MS2
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scans were acquired in the Orbitrap mode with a maximum
injection time of 35 ms, quadrupole isolation, an isolation
window of 1.6 m/z, higher-energy collisional dissociation of
30%, and an automatic gain control target value of 5 × 104.
MS data analysis
MS/MS spectra were extracted from raw data files and con-
verted into .mgf files using a Proteome Discoverer Software
(version 2.1.0.62). These .mgf files were then independently
searched against human database using an in-house Mascot
server (version 2.6; Matrix Science). Mass tolerances were ±10
ppm for MS peaks, and ±25 ppm for MS/MS fragment ions.
Trypsin specificity was used, allowing for one missed cleavage.
Met oxidation, protein amino-terminal acetylation, amino-
terminal biotinylation, lysine biotinylation, and peptide
amino-terminal pyroglutamic acid formation were allowed as
variable modifications, while carbamidomethyl of Cys was set
as a fixed modification. Scaffold (version 4.8; Proteome Soft-
ware) was used to validate MS/MS-based peptide and protein
identifications. Peptide identifications were accepted if they
could be established at >95.0% probability as specified by the
Peptide Prophet algorithm. Protein identifications were ac-
cepted if they could be established at >99.0% probability and
contained at least two identified unique peptides.
To estimate relative protein levels, distributed normalized
spectral abundance factors (dNSAFs) were calculated for each
nonredundant protein, as described previously (Zhang et al.,
2010). Average dNSAFs were calculated for each protein using
replicates with nonzero dNSAF values. Enrichment of proteins
in streptavidin affinity purifications from KIF1C-BioID-
3xFLAG–tagged stable cell line relative to a control BioID stable
cell line was calculated for all replicates as the ratio of average
dNSAF (ratio = average dNSAFKIF1C-BioID:average dNSAFBioID).
The volcano plot (Fig. 1 D) was generated by plotting the
log2(fold enrichment) against the −log10(P value), where the P
value (two-tailed Student’s t test) was computed by comparing
the replicate dNSAF values of KIF1C-BioID to the BioID control.
Potential KIF1C interactions were included as significant if they
were not present in the control samples or were more than
threefold enriched in the KIF1C-BioID-3xFLAG dataset and had
P values <0.05.
Protein purification
KIF1C
Different KIF1C constructs were purified from 293T cells tran-
siently transfected with KIF1C-SNAPf-3xFLAG or KIF1CΔ794-807-
SNAPf-3xFLAG. Frozen cell pellets from 45 plates were
resuspended in 60 ml of BRB80 lysis buffer (80 mM Pipes, pH
6.8, 1 mM MgCl2, 1 mM EGTA, 10% glycerol, and 50 mM KOAc)
supplemented with 1 mM DTT, 0.5 mM ATP, 0.2% Triton X-
100, and 1× protease inhibitor cocktail [cOmplete Protease In-
hibitor Cocktail; Roche]) and gently mixed at 4°C for 15 min.
The lysed cells were then centrifuged at 30,000 rpm in a Ti70
rotor (Beckman Coulter) at 4°C for 30 min. The clarified lysate
was retrieved and added to 0.7 ml packed anti-FLAG M2 aga-
rose resin (Sigma-Aldrich) and incubated with gentle mixing at
4°C for 16 h. After incubation, the lysate/resin mixture was
centrifuged at 1,000 rpm for 2 min at 4°C to pellet the resin, the
supernatant was decanted, and the resin was transferred to a
column at 4°C. The column was washed with 50 ml low-salt
wash buffer (80 mM Pipes, pH 6.8, 1 mM MgCl2, 1 mM EGTA,
10% glycerol, 50 mM KOAc, 1 mM DTT, 0.02% Triton X-100,
and 0.5 mM Pefabloc), 100 ml high-salt wash buffer (80 mM
Pipes, pH 6.8, 1 mM MgCl2, 1 mM EGTA, 10% glycerol, 250 mM
KOAc, 1 mM DTT, 0.02% Triton X-100, and 0.5 mM Pefabloc),
and finally 150 ml low-salt wash buffer. After the final wash,
the resin was resuspended in an equal volume of low-salt wash
buffer (700 µl) and moved to room temperature, and 7 µl of
SNAP-TMR (Promega) was added and mixed. The mixture was
incubated in the dark at room temperature for 10 min. The
columnwas returned to 4°C and washed with 100ml of low-salt
wash buffer. The labeling steps were omitted when unlabeled
protein was desired. The resin was resuspended in 700 µl of
low-salt wash buffer containing 2 mg/ml 3xFLAG peptide
(ApexBio) and incubated for 30min at 4°C. The purified protein
was concentrated using a 100-kD molecular weight cut-off
(MWCO) centrifugal filter (Amicon Ultra; Millipore). Each
purified KIF1C construct was aliquoted, and aliquots were snap-
frozen in liquid N2 and stored at −80°C. Protein purity was
determined on Sypro (Thermo Fisher Scientific)–stained SDS-
PAGE gels. The labeling efficiency of KIF1C-SNAPf-TMR was
86% and of KIF1CΔ794-807-SNAPf-TMR was 99%.
Full-length Hook3
Full-length wild-type Hook3 (Halo-Hook3[1–718]-3xFLAG) was
purified from transiently transfected 293T cells. Frozen cells
(90 × 15-cm plates) were resuspended in 80 ml of DLB buffer
supplemented with 1 mMDTT, 0.5 mMATP, 0.2% Triton X-100,
and 1× protease inhibitor cocktail (cOmplete Protease Inhibitor
Cocktail; Roche) and gently mixed at 4°C for 15 min. The lysed
cells were then centrifuged at 30,000 rpm in a Ti70 rotor
(Beckman Coulter) at 4°C for 30 min. The clarified lysate was
retrieved and added to 1.5 ml packed anti-FLAG M2 agarose
(Sigma-Aldrich) and incubated with gentle mixing at 4°C for 16
h. After incubation, the lysate/resin mixture was centrifuged at
1,000 rpm for 2 min at 4°C to pellet the resin, the supernatant
was decanted, and the resin was transferred to a column at 4°C.
The column was washed with 100 ml low-salt wash buffer
(30 mM Hepes, pH 7.4, 50 mM KOAc, 2 mM MgOAc, 1 mM
EGTA, pH 7.5, 10% glycerol, 1 mM DTT, 0.5 mM ATP, 0.5 mM
Pefabloc, and 0.02% Triton X-100), 100 ml high-salt wash buffer
(30 mM Hepes, pH 7.4, 250 mM KOAc, 2 mM MgOAc, 1 mM
EGTA, pH 7.5, 10% glycerol, 1 mM DTT, 0.5 mM ATP, 0.5 mM
Pefabloc, and 0.02% Triton X-100), and finally with 100 ml low-
salt wash buffer. The resin was then resuspended in an equal
volume of low-salt wash buffer (1.5 ml), and 20 µl of 1 mM
Halo–Alexa Fluor 488 was added and mixed. The mixture was
incubated in the dark at room temperature for 10 min. The
column was returned to 4°C and washed with 100 ml of low-salt
wash buffer. The resin was resuspended in 1,000 µl of low-salt
wash buffer containing 2 mg/ml 3xFLAG peptide (ApexBio) and
incubated for 30 min at 4°C. The mixture was retrieved and
centrifuged through a small filter column to remove the resin.
The eluate was retrieved, and 500 µl was loaded onto a Superose
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6 Increase 10/300 GL Column connected to an AKTA FPLC (GE
Healthcare) and run in “GF150” buffer (25 mM Hepes, pH 7.4,
150 mM KCl, 1 mM MgCl2, and 1 mM DTT). Peak fractions
containing Alexa Fluor 488–labeled Halo-Hook3-3xFLAG were
pooled and concentrated, and buffer was exchanged to GF150 +
10% glycerol using a 100-kD MWCO centrifugal filter (Amicon
Ultra; Millipore). Aliquots were snap-frozen in liquid N2 and
stored at −80°C. Protein purity was checked on a Sypro (Thermo
Fisher Scientific)–stained SDS-PAGE gel. The labeling efficiency
was 91%.
Hook3Hook2 chimera
Hook3Hook2 chimera (ZZ-TEV-Halo-Hook3[1–552]-Hook2[548–719])
was purified from baculovirus-infected Sf9 insect cells. Cell pellets
from 800 ml culture were resuspended in DLB supplemented with
0.5 mM ATP, 0.2% Triton X-100, 300 mM KOAc, and 1× protease
inhibitor cocktail (cOmplete Protease Inhibitor Cocktail; Roche) and
lysed using a Dounce homogenizer (15 strokes with loose plunger
and 10 strokes with tight plunger). The lysate was clarified by
centrifuging at 183,960 × g for 30 min. The clarified lysate was
retrieved and added to 1.5 ml of IgG Sepharose 6 Fast Flow affinity
resin (GE Healthcare), preequilibrated in DLB buffer, and incubated
with gentle mixing at 4°C for 2 h. After incubation, the lysate/resin
mixture was centrifuged at 1,000 rpm for 2 min at 4°C to pellet the
resin, the supernatant was decanted, and the resin was transferred
to a column at 4°C. The column was washed with 100 ml low-salt
TEV buffer (10mMTris-HCl, pH 8, 2 mMMgOAc, 1 mM EGTA, pH
7.5, 10% glycerol, 1 mM DTT, and 250 mM KOAc), 100 ml high-salt
TEV buffer (10mMTris-HCl, pH 8, 2 mMMgOAc, 1 mM EGTA, pH
7.5, 10% glycerol, 1 mM DTT, and 500 mM KOAc), and finally
100 ml low-salt TEV buffer. The resin was then resuspended in an
equal volume of low-salt TEV buffer supplemented with 0.02%NP-
40 and TEV protease and incubated∼16 h followed by labeling with
20 µl of 1 mMHalo–Alexa Fluor 488. The mixture was incubated at
4°C in the dark for 2 h. After labeling, themixturewas retrieved and
centrifuged through a small filter column to remove the resin. The
eluate was retrieved, and 500 µl was loaded onto a Superose 6
Increase 10/300 GL Column connected to an AKTA FPLC (GE
Healthcare) and run in GF150 buffer. Peak fractions containing
Alexa Fluor 488–labeled Halo-Hook3Hook2-3xFLAGwere pooled and
concentrated, and buffer was exchanged to GF150 + 10% glycerol
using a 100-kD MWCO centrifugal filter (Amicon Ultra; Millipore).
Aliquots were snap-frozen in liquid N2 and stored at −80°C. Protein
purity was checked on a Sypro (Thermo Fisher Scientific)-stained
SDS-PAGE gel. The labeling efficiency was 94%.
Hook3NT
The Hook3NT (Strep-Halo-Hook3[1–552]) construct was trans-
formed into BL21-CodonPlus (DE3)-RIPL cells (Agilent). 2 liters
of cells were grown at 37°C in LB media to a 600-nm optical
density of 0.4–0.8 before the temperature was reduced to 18°C
and expression was induced with 0.5 mM IPTG. After 16–18 h,
the cells were harvested via centrifugation for 6 min at 4°C at
6,000 rpm in a Beckman Coulter JLA 8.1000 fixed-angle rotor.
Pellets were resuspended in 40 ml of DLB supplemented with
0.5 mM Pefabloc SC (Sigma-Aldrich) and 1 mg/ml lysozyme and
incubated at 4°C for 30 min. Cells were lysed via sonication
(Branson Digital Sonifier) and clarified via centrifugation at
66,000 × g for 30 min in a Ti70 rotor (Beckman Coulter) at
4°C. Supernatant was loaded onto a 5-ml StrepTrap column
(GE Healthcare) and washed with 50–100 ml of lysis buffer.
Strep-Halo-Hook3NT was eluted with 25–50 ml of elution
buffer (DLB with 3 mM d-Desthiobiotin). Elution was then
applied to a size exclusion chromatography Superose 6 In-
crease 10/300 GL column (GE Healthcare) that had been
equilibrated with GF150 buffer. Peak fractions containing Alexa
Fluor 488 Strep-Halo-Hook3NT were pooled and concentrated
using a 100-kD MWCO centrifugal filter (Amicon Ultra; Milli-
pore). Aliquots were snap-frozen in liquid N2 and stored at
−80°C. Protein purity was assayed by SDS-PGAE and Sypro
(Thermo Fisher Scientific) staining. The labeling efficiency
was 75%.
Dynein and dynactin
Dynein (IC2-SNAPf-3xFLAG) and dynactin (p62-Halo-3xFLAG)
were purified from stable cell line as previously described
(Redwine et al., 2017). Briefly, frozen pellets from 293T cells (80 ×
15-cm plates, dynein and 160 × 15-cm plates, dynactin) were
resuspended in DLB supplemented with 0.5 mM ATP, 0.2%
Triton X-100, and 1× protease inhibitor cocktail (cOmplete
Protease Inhibitor Cocktail; Roche) and gently mixed at 4°C for
15 min. The lysed cells were then centrifuged at 30,000 rpm in a
Ti70 rotor (Beckman Coulter) at 4°C for 30 min. The clarified
lysate was retrieved and added to 1.5 ml (dynein) or 3 ml (dy-
nactin) of packed anti-FLAG M2 agarose resin (Sigma-Aldrich)
and incubated with gentle mixing at 4°C for 16 h. After incuba-
tion, the lysate/resin mixture was centrifuged at 1,000 rpm for
2 min at 4°C to pellet the resin, and the supernatant was dec-
anted. The resin was transferred to a column at 4°C, and the
column was washed with 100 ml low-salt wash buffer (30 mM
Hepes, pH 7.4, 50 mMKOAc, 2 mMMgOAc, 1 mM EGTA, pH 7.5,
10% glycerol, 1 mM DTT, 0.5 mM ATP, 0.5 mM Pefabloc, and
0.02% Triton X-100), 100 ml high-salt wash buffer (30 mM
Hepes, pH 7.4, 250 mM KOAc, 2 mM MgOAc, 1 mM EGTA, pH
7.5, 10% glycerol, 1 mM DTT, 0.5 mM ATP, 0.5 mM Pefabloc, and
0.02% Triton X-100), and finally 50 ml low-salt wash buffer.
After the final wash, the resin was resuspended in an equal
volume of low-salt wash buffer and moved to room temperature,
and 15 µl of 1 mM SNAP–Alexa Fluor 647 was added and mixed.
The mixture was incubated in the dark at room temperature for
10min. The columnwas returned to 4°C andwashedwith 100ml
of low-salt wash buffer. The labeling steps were omitted when
unlabeled protein was desired. The resin was resuspended in
800 µl of low-salt wash buffer containing 2 mg/ml 3xFLAG
peptide (ApexBio) and incubated for 30 min at 4°C. The mixture
was retrieved and centrifuged through a small filter column to
remove the resin. The eluate was next loaded onto a Mono Q
5/50 GL 1-ml column on an AKTA FPLC (GE Healthcare). The
columnwaswashedwith 5ml buffer A (50mMTris-HCl, pH 8.0,
2 mMMgOAc, 1 mMEGTA, and 1mMDTT) and then subjected to
a 26-ml linear gradient from 35–100% buffer Bmixedwith buffer
A (buffer B = 50 mM Tris-HCl, pH 8.0, 1 M KOAc, 2 mMMgOAc,
1 mM EGTA, and 1 mM DTT), followed by 5 ml additional 100%
buffer B. Fractions containing pure dynein (∼60–70% Buffer B)
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or pure dynactin (∼75–80% buffer B) were pooled, and buffer
was exchanged through iterative rounds of dilution and con-
centration on a 100-kD MWCO centrifugal filter (Amicon Ultra;
Millipore) using GF150 buffer with 10% glycerol. Purity was
evaluated on SDS-PAGE gels, and protein aliquots were snap-
frozen in liquid N2 and stored at −80°C. The labeling efficiency
of dynein–Alexa Fluor 647 was 97%.
Microtubule preparation
Microtubules were polymerized from tubulin prepared from
bovine brain as previously described (Waterman-Storer, 2001).
Purified tubulin was labeled with Alexa Fluor 405 NHS Ester
(Thermo Fisher Scientific), Alexa Fluor 488 NHS Ester (Thermo
Fisher Scientific), N-ethylmaleimide (Thermo Fisher Scientific),
or biotin ester (biotin-X; Thermo Fisher Scientific) by a series of
polymerization and depolymerization steps. To make bio-
tinylated Alexa Fluor 405 or Alexa Fluor 488 microtubules,
fluorophore-labeled tubulin (10 µM) was mixed with biotin-
tubulin (10 µM) and unlabeled tubulin (10 µM). The tubulin
mixture was incubated on ice for 10 min followed by an addition
of an equal volume of polymerization buffer (2× BRB80 sup-
plemented with 2 mM DTT, 2 mMMgGTP, and 20% DMSO) and
incubation for 30min at 37°C. After incubation, an equal volume
of BRB80 supplemented with 1 mM DTT and 20 µM taxol was
added to the mixture, and microtubules were incubated for an
additional 10min at 37°C. Microtubules were used for up to 2 wk
after polymerization and diluted 1:150–1:200 before single-
molecule assays.
Polarity-marked microtubules were prepared according to
a previously described protocol with slight modifications
(Roberts et al., 2014). Brightly labeled, biotinylated microtu-
bule seeds were polymerized by mixing Alexa Fluor 405–
tubulin (10 µM), biotin-tubulin (10 µM), and unlabeled
tubulin (10 µM) with 0.5 mM guanylyl-(α,β)-methylene di-
phosphonate (GMP-CPP; Jena Bioscience) in BRB80 sup-
plemented with 1 mM DTT and incubating for 30 min at
37°C. Following the addition of 10× volume of BRB80, po-
lymerized seeds were pelleted in a benchtop centrifuge
(15 min at 16,100 × g) and resuspended in a volume of BRB80
equal to the original polymerization volume. GMP-CPP
seeds were then mixed with 1:5 diluted dim mix containing
12 µM 405-tubulin, 15 µM unlabeled tubulin, 10 µM biotin-
tubulin, and 15 µM N-ethylmaleimide–tubulin and incu-
bated for 30 min at 37°C. After incubation, an equal volume
of BRB80 supplemented with 1 mM DTT and 20 µM taxol
was added to the mixture, and microtubules were incubated
for additional 30 min at 37°C to generate polarity-marked
microtubules. 1:25 diluted polarity-marked microtubules
were flowed into flow chambers, and single-molecule mo-
tility analyses were performed as described below.
TIRF microscopy
Imaging was performed with an inverted microscope (Ti-E
Eclipse; Nikon) equipped with a 100× 1.49 NA oil immersion
objective (Plano Apo; Nikon). The xy position of the stage was
controlled by ProScan linear motor stage controller (Prior). The
microscope was equipped with an MLC400B laser launch
(Agilent) equipped with 405-nm (30 mW), 488-nm (90
mW), 561-nm (90 mW), and 640-nm (170 mW) laser lines.
The excitation and emission paths were filtered using ap-
propriate single bandpass filter cubes (Chroma). The
emitted signals were detected with an electron multiplying
charge coupled device camera (iXon Ultra 888; Andor
Technology). Illumination and image acquisition were
controlled by NIS Elements Advanced Research software
(Nikon).
Single-molecule motility assays
Single-molecule motility assays were performed in flow cham-
bers using the TIRF microscopy setup described above. Bio-
tinylated and PEGylated coverslips (Microsurfaces) were used to
reduce nonspecific binding. Microtubules contained ∼10%
biotin-tubulin for attachment to a streptavidin-coated coverslip
and ∼10% Alexa Fluor 405 or 488 (Thermo Fisher Scientific)
tubulin for visualization. Imaging buffer was DLB supplemented
with 20 µM taxol, 1 mg/ml casein, 1 mM Mg-ATP, 71.5 mM β
mercaptoethanol, an oxygen scavenger system, 0.4% glucose,
45 µg/ml glucose catalase (Sigma-Aldrich), and 1.15 mg/ml glu-
cose oxidase (Sigma-Aldrich). Images were recorded every
0.3–0.4 s for 3 min. Movies showing significant drift were not
analyzed.
For two-color motility assays of KIF1C with Hook3, 1.125
nM KIF1C-SNAPf-AlexaTMR was mixed with 2.25 nM
Hook3–Alexa Fluor 488 or 2.25 nM Hook3Hook2–Alexa Fluor
488. The two-color motility measurements of dynein, dy-
nactin, and different Hook3 constructs were all performed
with 450 pM dynein–Alexa Fluor 647, 900 pM unlabeled dy-
nactin, and 3.25 pM Hook3 (Hook3NT–Alexa Fluor 488,
Hook3–Alexa Fluor 488, or Hook3Hook2–Alexa Fluor 488). The
three-color single-molecule motility experiments were per-
formed with 450 pM dynein–Alexa Fluor 647, 900 pM unla-
beled dynactin, 130 nM Hook3 (Hook3–Alexa Fluor 488 or
Hook3Hook2–Alexa Fluor 488), and 0.45 nM KIF1C (KIF1C-
SNAPf-TMR or KIF1CΔ794-807-SNAPf-TMR). Two-color motil-
ity measurements with increasing concentrations of KIF1C
were performed with 450 pM dynein–Alexa Fluor 647, 900
pM unlabeled dynactin, 3.25 pM Hook3, and the following
concentrations of unlabeled KIF1C: 450 pM, 900 pM, or 1.8
nM. Each protein mixture was incubated on ice for 10 min
before TIRF imaging. The order of protein addition or pre-
incubation of Hook3 with KIF1C before dynein and dynactin
addition did not affect complex behavior.
Bleaching analysis
Bleach step analysis was performed in a flow chamber as de-
scribed above with biotin–Alexa Fluor 488 microtubules im-
mobilized to the coverslips. 560 pM KIF1C-TMR in the presence
or absence of 1.125 nM Hook3-488 was flowed into the chamber
in the presence of DLB supplemented with 1 mM AMP-PNP
(Sigma-Aldrich), 100 µM taxol, and 0.1 mg/ml casein. Images
were acquired every 100 ms for 160 s using a 562-nm laser at
50% power. Images were analyzed in ImageJ with Plot Profile
function. Steps were manually counted from individual spot
profiles.
Kendrick et al. Journal of Cell Biology 2998
Hook3 is a scaffold for opposite-polarity motors https://doi.org/10.1083/jcb.201812170
TIRF data analysis
The velocity of moving particles was calculated from kymo-
graphs generated in ImageJ as described previously (Roberts
et al., 2014). Velocities were only calculated from molecules
that moved processively for more than five frames. Nonmotile
or diffusive events were not considered in velocity calculation.
Processive events were defined as events that move unidirec-
tionally and do not exhibit directional changes >600 nm. Dif-
fusive events were defined as events that exhibit at least one
bidirectional movement >600 nm in each direction. Single-
molecule movements that change apparent behavior (e.g., shift
from nonmotile to processive) were considered asmulti-velocity
events and counted as multiple events. For run length analysis,
the length of each track in a multi-velocity event was combined
to calculate total run length. Pausing frequency was calculated
bymeasuring the number of pauses in multi-velocity events and
dividing this number by the total run length of the multi-
velocity event. Landing rates were calculated by counting the
number of processive events that start after the first frame and
end before the last frame of each movie and dividing this
number by the microtubule length and total movie time.
Data visualization and statistical analyses were performed
using GraphPad Prism (8.0d; GraphPad Software), Excel (ver-
sion 16.20; Microsoft), XLSTAT (2019.1.3.; Addinsoft), and Im-
ageJ (2.0). Brightness and contrast were adjusted in ImageJ for
all videos and kymographs. In addition, images in Fig. 5 B were
manually colored (yellow) in Photoshop (version 20; Photoshop
CC) to highlight the three-color colocalized runs. For run length
analysis, data were plotted as a 1-cumulative probability distri-
bution and fit to a one-phase exponential decay function (least
squares fit). Statistical analyses for velocities, pausing fre-
quency, and landing rates were performed using an unpaired
t test with Welch’s correction. Errors for run length analysis of
KIF1C and KIF1C/Hook3 were generated using a bootstrapping
method (each run length value was resampled 200 times) and
statistical significance was analyzed using an unpaired t test
with Welch’s correction. Statistical comparisons of the plus end
and minus end moving events were performed using one-way
ANOVA with Tukey post-test. The exact value of N and evalu-
ation of statistical significance are described in the corre-
sponding figures and figure legends. All experiments were
analyzed from at least three independent replicates unless oth-
erwise stated.
Sequence alignment
Protein sequences of different Hook isoforms were obtained
from UniProt. Sequence alignments were performed with
Clustal Omega web services (McWilliam et al., 2013) and anno-
tated using Jalview (Biasini et al., 2014).
Online supplemental material
Fig. S1 shows the motile properties of KIF1C in the presence and
absence of Hook3. Fig. S2 shows the mapping of the Hook3 and
KIF1C interaction. Fig. S3 shows the motile properties of dynein
in the presence of purified full-length Hook3, the Hook3 amino
terminus, and a Hook3-Hook2 chimera. Fig. S4 shows that
Hook3 scaffolds dynein and KIF1C for opposite polarity motility.
Fig. S5 shows that dynactin localization is unaffected by KIF1C
expression. Video 1 shows the movement of KIF1C-TMR on 405-
labeled microtubules. Video 2 shows the movement of KIF1C-
TMR in the presence of Hook3-488 on 405-labeledmicrotubules.
Video 3 shows the movement of KIF1CΔ794-807-TMR on 405-
labeled microtubules. Video 4 shows the movement of
KIF1CΔ794-807-TMR in the presence of Hook3-488 on 405-labeled
microtubules. Video 5 shows the movement of KIF1C-TMR in the
presence of Hook3Hook2-488 on 405-labeled microtubules. Video
6 shows the movement of dynein-647, dynactin, and Hook3-488
on 405-labeled microtubules. Video 7 shows an example of a
movement of dynein-647, dynactin, Hook3-488, and KIF1C-TMR
on 405-labeled microtubules. Video 8 shows an example of a
movement of dynein-647, dynactin, Hook3-488, and KIF1C-TMR
on 405-labeled microtubules. Table S1 lists the MS results gen-
erated from the KIF1C-BioID experiment.
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